KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Shares Issued: 2013-2025

Historic Shares Issued for Xenon Pharmaceuticals (XENE) over the last 5 years, with Sep 2025 value amounting to $2.4 million.

  • Xenon Pharmaceuticals' Shares Issued was N/A to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.7 million, marking a year-over-year change of. This contributed to the annual value of $12.1 million for FY2024, which is 96.58% down from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Shares Issued of $2.4 million as of Q3 2025, which was up 3,530.77% from $65,000 recorded in Q2 2025.
  • Xenon Pharmaceuticals' Shares Issued's 5-year high stood at $324.0 million during Q4 2023, with a 5-year trough of $15,000 in Q4 2021.
  • In the last 3 years, Xenon Pharmaceuticals' Shares Issued had a median value of $2.4 million in 2025 and averaged $67.9 million.
  • Per our database at Business Quant, Xenon Pharmaceuticals' Shares Issued spiked by 1,847,013.33% in 2022 and then plummeted by 96.27% in 2024.
  • Quarterly analysis of 5 years shows Xenon Pharmaceuticals' Shares Issued stood at $15,000 in 2021, then soared by 1,847,013.33% to $277.1 million in 2022, then increased by 16.93% to $324.0 million in 2023, then crashed by 96.27% to $12.1 million in 2024, then reached $2.4 million in 2025.
  • Its Shares Issued stands at $2.4 million for Q3 2025, versus $65,000 for Q2 2025 and $1.2 million for Q1 2025.